Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    1
    33%
    Phase 1/2
    2
    67%

    Phase Distribution

    0

    Early Stage

    3

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 1/2Combined phases
    2(66.7%)
    Phase 2Efficacy & side effects
    1(33.3%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(1)
    Other(2)

    Detailed Status

    unknown2
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 1/2

    Trials by Phase

    Phase 1/22 (66.7%)
    Phase 21 (33.3%)

    Trials by Status

    completed133%
    unknown267%

    Recent Activity

    0 active trials
    Showing 3 of 3
    unknownphase_2

    Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

    NCT05535803
    unknownphase_1_2

    Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells

    NCT05167552
    completedphase_1_2

    Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

    NCT03130374

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT05535803Phase 2

    Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

    Unknown
    NCT05167552Phase 1/2

    Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells

    Unknown
    NCT03130374Phase 1/2

    Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Biological
    Total Trials
    3